Chase Coleman’s Outset Medical OM Stock Holding History

Chase Coleman’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,667	Closed	-$2.54M	–	132
2021 Q4	$2.54M	Hold	3,667	–	–	0.01%	148
2021 Q3	$2.72M	Hold	3,667	–	–	0.01%	143
2021 Q2	$2.75M	Hold	3,667	–	–	0.01%	132
2021 Q1	$2.99M	Hold	3,667	–	–	0.01%	111
2020 Q4	$3.13M	Hold	3,667	–	–	0.01%	88
2020 Q3	$2.75M	Buy	+3,667	New	+$3.01M	0.01%	81

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Chase Coleman's OM Position: Q1 2022 in Review

Chase Coleman sold out of Outset Medical (OM) in Q1 2022, closing a stake of 3,667 shares — an estimated $2.54M sold.

Chase Coleman first reported a position in OM in Q3 2020 and held it in 6 quarters. The position peaked at $3.13M in Q4 2020. 152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

Chase Coleman reported no remaining Outset Medical position as of Q1 2022 after selling out during the quarter.
Chase Coleman sold 3,667 Outset Medical shares in Q1 2022, an estimated $2.54M.
Chase Coleman first reported a position in Outset Medical in Q3 2020 and held it in 6 quarters.
Chase Coleman's Outset Medical position peaked at $3.13M in Q4 2020.
152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on Tiger Global Management's 13F filing for Q1 2022, filed 16 May 2022.